ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,045Medicare Part D Prescriptions Filled, Including Refills

Rank: 864 out of 3734

$434K Total Retail Price of All Prescriptions

Rank: 937 out of 3734

306 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 6,854 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 306 263 1 3
OMEPRAZOLE 281 250 2 4
LEVOTHYROXINE SODIUM 276 266 3 2
POTASSIUM CHLORIDE 275 241 4 19
WARFARIN SODIUM 256 228 5 10
METOPROLOL SUCCINATE 239 215 6 14
PRAVASTATIN SODIUM 228 198 7 15
FUROSEMIDE 219 200 8 7
SIMVASTATIN 191 185 9 1
METFORMIN HCL 164 128 10 8
AMLODIPINE BESYLATE 152 136 11 5
HYDROCHLOROTHIAZIDE 144 107 12 9
GABAPENTIN 116 92 13 17
ISOSORBIDE MONONITRATE ER 113 104 14 34
DOXAZOSIN MESYLATE 105 105 15 100
TRAMADOL HCL 105 101 15 20
BISOPROLOL-HYDROCHLOROTHIAZIDE 104 84 17 145
METOPROLOL TARTRATE 103 84 18 6
HYDROCODONE-ACETAMINOPHEN 103 74 S3 18 12
NEXIUM 102 90 20 36
RAMIPRIL 97 97 21 91
TAMSULOSIN HCL 96 89 22 29
ATORVASTATIN CALCIUM 94 85 23 11
ATENOLOL 93 84 24 13
DILTIAZEM 24HR ER 85 83 25 86
FENOFIBRATE 82 73 26 81
SERTRALINE HCL 81 66 27 18
BISOPROLOL FUMARATE 78 72 28 194
PLAVIX 70 70 29 39
MELOXICAM 70 50 29 52
CLOPIDOGREL 69 65 31 23
GLIMEPIRIDE 65 62 32 37
GLYBURIDE 59 43 R 33 64
GUANFACINE HCL 59 38 R 33 403
PANTOPRAZOLE SODIUM 58 57 35 22
DIOVAN 56 41 36 31
ADVAIR DISKUS 56 44 36 35
ENALAPRIL MALEATE 53 53 38 63
ZOLPIDEM TARTRATE 51 33 39 24
METFORMIN HCL ER 50 50 40 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.